Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
10.1002/cncr.26372
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/124662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-124662 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1246622023-10-29T23:28:51Z Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung De Lima Lopes Jr., G. Segel, J.E. Tan, D.S.W. Do, Y.K. Mok, T. Finkelstein, E.A. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Asia cost-effectiveness economic evaluation epidermal growth factor receptor gefitinib lung adenocarcinoma 10.1002/cncr.26372 Cancer 118 4 1032-1039 CANCA 2016-06-01T10:25:10Z 2016-06-01T10:25:10Z 2012-02-15 Article De Lima Lopes Jr., G., Segel, J.E., Tan, D.S.W., Do, Y.K., Mok, T., Finkelstein, E.A. (2012-02-15). Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer 118 (4) : 1032-1039. ScholarBank@NUS Repository. https://doi.org/10.1002/cncr.26372 0008543X http://scholarbank.nus.edu.sg/handle/10635/124662 000299834300021 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Asia cost-effectiveness economic evaluation epidermal growth factor receptor gefitinib lung adenocarcinoma |
| spellingShingle |
Asia cost-effectiveness economic evaluation epidermal growth factor receptor gefitinib lung adenocarcinoma De Lima Lopes Jr., G. Segel, J.E. Tan, D.S.W. Do, Y.K. Mok, T. Finkelstein, E.A. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| description |
10.1002/cncr.26372 |
| author2 |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
| author_facet |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE De Lima Lopes Jr., G. Segel, J.E. Tan, D.S.W. Do, Y.K. Mok, T. Finkelstein, E.A. |
| format |
Article |
| author |
De Lima Lopes Jr., G. Segel, J.E. Tan, D.S.W. Do, Y.K. Mok, T. Finkelstein, E.A. |
| author_sort |
De Lima Lopes Jr., G. |
| title |
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| title_short |
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| title_full |
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| title_fullStr |
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| title_full_unstemmed |
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| title_sort |
cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung |
| publishDate |
2016 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/124662 |
| _version_ |
1781789899521785856 |